Company intelligence

Dare Bioscience

Biotech

Recent changes

  1. Aug 26, 2026Small-Cap S-1 Bundle: Dare Bioscience, RZ Wellness Pulse story
  2. Aug 26, 2026Dare Bioscience Files S-1 After $5.3M Stock Offering Pulse story
  3. Aug 17, 2026Raised $12.4M SEC EDGAR Form D

Funding History

1 event · sources dated per row
DateEventAmountValuationInvestorsSource
Aug 17, 2026funding round$12.4M
SEC EDGAR Form D

Latest Pulse

  1. Dare Bioscience Files S-1 After $5.3M Stock OfferingWomen's health biopharma Dare Bioscience filed a new S-1 tied to a $5.3 million registered direct offering that closed in August, as the sub-$1 stock works to fund Phase 3 trials for its hormone-free contraceptive Ovaprene.
  2. Small-Cap S-1 Bundle: Dare Bioscience, RZ WellnessDare Bioscience registered resale shares tied to an August warrant placement, while RZ Wellness amended its S-1 to sell 5.5 million shares at 3 cents apiece for a $165,000 OTCQB offering -- among the smallest public raises on record.

Coverage Timeline

newest first
  1. IPODare Bioscience Files S-1 After $5.3M Stock Offering
  2. IPOSmall-Cap S-1 Bundle: Dare Bioscience, RZ Wellness

All Coverage

Related Companies

Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction